May 26, 2017
ASCO 2017 is primarily setting the stage for future as it relates to Prostate Cancer – a large number of presentations are focused on early stage data from new compounds and/or combinations of existing. The truly practice impacting trials such as IMbassador250, ARASENS, PROfound and TRITON3 will be touched upon […]
May 23, 2017
Colorectal Cancer Diagnostics and monitoring CRC diagnostics and monitoring follows two pronged strategy Diagnostic tools such as Colonoscopy: Specific, Can Remove Polyps and Take Biopsies. Adverse: Can cause perforation, Can miss small adenomas Flexible sigmoidoscopy: Specific, Can Remove Polyps and Take Biopsies. Adverse: Reduced risk of perforation Double-contrast barium enema: […]
May 22, 2017
There are four areas of innovation that are noticeable both in isolation and how they feed into each other for a transformation in cancer care “Big data” and Bioinformatics – rapidly developing data management systems and analytics e.g. NGS that will enable us to collect, analyze and learn from vast amounts […]
April 12, 2017
Malignant Pleural mesothelioma is a relatively rare but aggressive form of cancer with very poor prognosis. Platinum-based chemotherapy has been the only therapeutic option in first-line. Currently, the efficacy of second-line therapy remains unproven and is a major unmet need. The diagnostic markers too lack specificity and are yet not effective to detect mesothelioma in early stages.
This infographic highlights the types of pleural mesothelioma, current clinical research, biomarkers and future outlook.
April 6, 2017
Mesothelioma, considered as a rare and occupational related cancer, is likely to become more common due to increasing exposure to Asbestos. Several countries are yet to see the peak incidence, whereas in some countries it is misdiagnosed or under reported. This infographic attempts to provide the basic statistics around Mesothelioma to understand the impact of this disease on an individual and country level.